CBD is an attractive opportunity for $PBIO's proprietary UST platform. The company believes that the nutraceuticals, topicals and cosmetics, and food and beverage markets could be 10-50 times larger. They will be addressing these additional market opportunities in parallel with their efforts in CBD. https://www.pressurebiosciences.com/pressure-...nology-pct
